Journal of Pharmaceutical Regulatory Affairs represents one of the leading International online platforms for communication and exchange of scholarly information on the current and prevailing laws and the regulatory concepts as applicable to the development and commercialization of pharmaceutical & biomedical products; food; beverages; biotech products and cosmetics originating from across the world. The journal publishes peer-reviewed articles under open access creative commons attribution license terms and are of immense relevance to the pharmacy students, physicians, clinicians, pharmaceutical & biopharmaceutical industrialists, regulatory affair professionals, manufacturers of medical devices and equipment, practicing attorneys, regulators, as well as academic and research community engaged in the designing and development of new drugs. The journal offers wide coverage of topics including trends and guidelines of various National and International regulatory agencies, Pharmacovigilance, new drug application processes, protocols of achieving regulatory compliance, legislative revisions, regulatory approvals, marketing practices, as well as the formulation & streamlining of good manufacturing practice. The journal’s core focus is on the procedures, protocols, standards & policies, pharmaceutical regulations, quality control and quality assurance of drug development. Journal of Pharmaceutical Regulatory Affairs represents one of the leading International online platforms for communication and exchange of scholarly information on the current and prevailing laws and the regulatory concepts as applicable to the development and commercialization of pharmaceutical & biomedical.
A statistical representation of global users for Pharmaceutical Regulatory Affairs: Open Access (Source: Google Analytics)
A statistical representation of global users for Pharmaceutical Regulatory Affairs: Open Access (Source: Google Analytics)
Hilaris operates more than 300 journals covering a wide range of subjects including Clinical, Biological, Biomedical, Pharmaceutical Sciences, Engineering & Technology, Business and Management.
The metrics and benchmark details furnished below reflect the popularity of our journals among the academic, scientific, industrial and general community. Authors and Editors profiles enlisted in our sites are gaining tremendous response as they are greatly shared and viewed by the colleagues and acquaints online.
Hilaris journals have so far received 2,572,994 sessions which confirm the outstanding pool of new users and visitors. Hilaris Journals works on Open Access publishing model, hence they are the best choice for the scholars and authors worldwide. We understand the importance of timely communication and our efficient and quick review process avoids unnecessary delays in the production, publication and circulation of the published material worldwide with in no time while enhancing the visibility of the authors and conferring credibility to scholars and readers.
The promotion of the individual author contributions is taken care of and hence the authors enjoy the reputation among global audience. Hilaris Journals values the contributions by the authors and takes adequate measures in propagating and promoting their outcomes by permanently archiving as well.
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report